BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Gyre Therapeutics Inc.

Headquarters: San Diego, CA, United States
Year Founded: 1997
Status: Public
Industry Sector: HealthTechnology
CEO: Han Ying, PhD
Number Of Employees: 5
Enterprise Value: $1,247,761,665
PE Ratio: 79.83
Exchange/Ticker 1: NASDAQ:GYRE
Exchange/Ticker 2: N/A
Latest Market Cap: $875,555,904

BioCentury | Jan 10, 2024
Finance

4Q23 Wrap: Turning up

Winners, losers in biotech stock tiers in 4Q23
Items per page:
1 - 1 of 1